| Introduction | For Patients | For Science | For Society | Looking Ahead A Legacy of Protection – Powered by Partnership and Education Papua New Guinea (PNG) Snakebite Partnership Approximately 10% of CSL’s annual antivenom production is donated to Papua New Guinea, where snakebite continues to pose a major public health threat. 560 vials of antivenom distributed across 15 provinces in 2025 70+ health facilities supplied with lifesaving treatment 1,189 healthcare workers trained in snakebite assessment, antivenom use and patient reporting 3k+ lives saved through the partnership since it began ~25% of patients treated have been children Since the 1930s, CSL Seqirus has helped protect communities from some of Australia's most dangerous venomous animals through the manufacture of lifesaving antivenoms. At the heart of this work is a unique partnership with the Australian Reptile Park. For more than 70 years, the Park's specialist keepers have supplied snake and spider venom essential for antivenom production, enabling CSL Seqirus to transform a natural hazard into lifesaving protection. In FY26, CSL Seqirus expanded its partnership with the Australian Reptile Park through a three-year sponsorship, valued at A$210,000 AUD supporting education, awareness and training initiatives focused on venomous creatures and first aid for bites and stings. By combining public education with one of Australia's longestrunning scientific partnerships, the initiative helps strengthen community resilience and supports the broader mission of saving lives through prevention and access to lifesaving antivenoms. Together, this enduring collaboration between CSL and the Reptile Park has contributed to saving more than 25,000 lives, demonstrating the power of science, expertise and partnership to protect vulnerable communities. 20 | CSL IMPACT REPORT 2026
RkJQdWJsaXNoZXIy MjE2NDg3